Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by AMANDA ROSEWELL SHAW and Greyson Biegert.
AMANDA ROSEWELL SHAW
Connection Strength
0.717
Greyson Biegert
  1. IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer. Mol Ther Oncol. 2024 Dec 19; 32(4):200899.
    View in: PubMed
    Score: 0.246
  2. HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy. Cancers (Basel). 2022 Jun 02; 14(11).
    View in: PubMed
    Score: 0.208
  3. Current development in adenoviral vectors for cancer immunotherapy. Mol Ther Oncolytics. 2021 Dec 17; 23:571-581.
    View in: PubMed
    Score: 0.201
  4. Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. J Immunother Cancer. 2024 Dec 09; 12(12).
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.